Severe hyperglycaemia following pazopanib treatment: The role of drug-drug-gene interactions in a patient with metastatic renal cell carcinoma-A case report.
Darija Kuruc PojeNada BožinaLivija ŠimičevićIgor ŽabićPublished in: Journal of clinical pharmacy and therapeutics (2020)
The pharmacogenetic profiling of the patient on polypharmacy enabled better management of pazopanib therapy.